martes, 4 de diciembre de 2018

Selected NIAID Science News Highlights of 2018 | NIH: National Institute of Allergy and Infectious Diseases

Selected NIAID Science News Highlights of 2018 | NIH: National Institute of Allergy and Infectious Diseases

NIAID Logo



Selected NIAID Science News Highlights of 2018

Collage of RSV particles, Ebola treatment, M. tuberculosis bacteria and eczema treatment



As 2019 approaches, a new slideshow highlights selected NIAID science news from the past year. NIAID scientists and NIAID-supported researchers made significant advances in understanding and treating allergic, immunologic, autoimmune and infectious diseases. Other work accelerated progress toward development of novel, safe and effective vaccines, including a universal flu vaccine. In addition, NIAID issued a strategic plan to reinvigorate research on tuberculosis, the leading infectious cause of death worldwide.

View the slideshow

No hay comentarios:

Publicar un comentario